Alexandria Real Estate Equities
ARE
#2214
Rank
NZ$14.06 B
Marketcap
NZ$81.17
Share price
-4.30%
Change (1 day)
-49.98%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -NZ$1.71 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are NZ$2.94 Billion. a decrease over its 2024 earnings that were of NZ$1.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$1.7 Billion-242.13%
2024 NZ$1.19 B96.11%
2023 NZ$0.60 B-53.56%
2022 NZ$1.31 B-3.96%
2021 NZ$1.36 B-20.26%
2020 NZ$1.71 B72.88%
2019 NZ$0.98 B3.11%
2018 NZ$0.95 B73.54%
2017 NZ$0.55 B464.88%
2016 NZ$97.89 M-77.32%
2015 NZ$0.43 B36.31%
2014 NZ$0.31 B-10.81%
2013 NZ$0.35 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$20.30 B-1,297.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.54 B-2,373.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.12 B-932.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.93 B-1,098.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.70 B-200.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.75 B-911.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.22 B-113.16%๐Ÿ‡บ๐Ÿ‡ธ USA